Meeting
2023 ASCO Quality Care Symposium
Healthcare contact days for patients with stage IV non-small cell lung cancer (NSCLC) in Ontario: A population-based study.
Authors
Arjun Gupta
University of Minnesota Masonic Cancer Center, Minneapolis, MN
Arjun Gupta, Paul Nguyen, Christopher M. Booth, Timothy P. Hanna
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship
Sub Track
Care Coordination, Cost, and Education
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 484)
DOI
10.1200/OP.2023.19.11_suppl.484
Abstract #
484
Poster Bd #
L10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Associations of frailty with overall survival (OS) and functional decline among older adults with non–small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/or targeted therapy.
First Author: Howard Jinsoo Lee Jr.
Poster
2023 ASCO Annual Meeting
Real-world testing and treatment patterns among patients with stage IV non-small cell lung cancer: A retrospective observational study.
First Author: Jeffrey A. Scott
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2021 ASCO Quality Care Symposium
Overall survival benefits of advances in NSCLC systemic treatments: Younger versus older adults.
First Author: Bonnie Leung